SouthState Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80
Closed -$618 1446
2025
Q3
$618 Sell
80
-569
-88% -$4.44K ﹤0.01% 1202
2025
Q2
$5.65K Buy
649
+500
+336% +$3.62K ﹤0.01% 890
2025
Q1
$1.19K Buy
149
+69
+86% +$698 ﹤0.01% 1292
2024
Q4
$727 Hold
80
﹤0.01% 650
2024
Q3
$734 Hold
80
﹤0.01% 589
2024
Q2
$782 Hold
80
﹤0.01% 616
2024
Q1
$1.21K Hold
80
﹤0.01% 639
2023
Q4
$1.72K Hold
80
﹤0.01% 546
2023
Q3
$1.49K Hold
80
﹤0.01% 579
2023
Q2
$2.03K Hold
80
﹤0.01% 549
2023
Q1
$2.07K Hold
80
﹤0.01% 598
2022
Q4
$1.89K Hold
80
﹤0.01% 654
2022
Q3
$2K Hold
80
﹤0.01% 647
2022
Q2
$3K Hold
80
﹤0.01% 663
2022
Q1
$6K Hold
80
﹤0.01% 634
2021
Q4
$7K Hold
80
﹤0.01% 611
2021
Q3
$10K Buy
+80
New +$11.6K ﹤0.01% 488

Other funds holding TDOC

SouthState Corp's TDOC Position: Q4 2025 in Review

SouthState Corp sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 80 shares — an estimated $618 sold.

SouthState Corp first reported a position in TDOC in Q3 2021 and held it in 17 quarters. The position peaked at $10K in Q3 2021. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • SouthState Corp reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • SouthState Corp sold 80 Teladoc Health shares in Q4 2025, an estimated $618.
  • SouthState Corp first reported a position in Teladoc Health in Q3 2021 and held it in 17 quarters.
  • SouthState Corp's Teladoc Health position peaked at $10K in Q3 2021.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on SouthState Corp's 13F filing for Q4 2025, filed 11 Feb 2026.